Related Experiment Video
Updated: Jun 3, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
From Escalate to Elevate: A New Paradigm for Comprehensive Cardiogenic Shock Management
Darshan H Brahmbhatt1, Sanjog Kalra2, Adriana Luk2
1Division of Cardiology, Mount Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada; Ted Rogers Centre for Heart Research, University Health Network, Toronto, Ontario, Canada; Division of Cardiology, Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.
This review discusses current treatments for cardiogenic shock (CS), a condition of low cardiac output (CO). It proposes a novel, immediate treatment approach to rapidly reverse shock and improve patient outcomes.
Area of Science:
- Cardiology
- Critical Care Medicine
- Hemodynamics
Background:
- Cardiogenic shock (CS) is a critical condition characterized by low cardiac output (CO) and end-organ dysfunction.
- Patient prognosis in CS is strongly linked to shock severity, necessitating intensive resource management.
- Current CS treatment relies on a reactive, feedback-based approach, leading to delays in intervention.
Purpose of the Study:
- To review current treatment paradigms for cardiogenic shock (CS).
- To introduce a novel, proactive treatment strategy for rapid amelioration of the shock state.
- To suggest new performance metrics for evaluating CS interventions.
Main Methods:
- Literature review of existing cardiogenic shock (CS) treatment strategies.
- Conceptualization of a novel, immediate intervention approach for CS.
- Proposal of new metrics for assessing treatment efficacy in CS.
Main Results:
- Current CS treatment methods involve incremental adjustments, potentially prolonging the shock state.
- A novel approach emphasizes immediate, decisive interventions to rapidly reverse CS.
- The proposed strategy aims to "break" the shock spiral more efficiently.
Conclusions:
- The standard CS treatment's feedback mechanism can cause critical delays.
- A proactive, immediate treatment strategy may offer superior outcomes in cardiogenic shock.
- New performance metrics are needed to evaluate the effectiveness of rapid CS interventions.
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure Drugs: Inotropic Agents
Pathophysiology of Cardiac Performance

